.png)
Ncardia Welcomes Divisional CEO, Dr. Jeroen de Groot
Development of next generation of high-tech equipment for cell culture applications.
Ncardia @ Neuroscience 2023: Insights & Scientific Advances
Ncardia @ ESGCT: Highlights from our week in Brussels
Press release: Ncardia And Cellistic Recruit Charles Jacques as new Chief Financial Officer
Advancing Gene Therapies: FDA's Milestone Approval for Duchenne Muscular Dystrophy Treatment
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
